Recurrent Pregnancy Loss in Guwahati: Causes, Diagnosis & How HomeIVF Can Help

Recurrent Pregnancy Loss is formally defined as two or more clinically confirmed pregnancy losses occurring before 20 weeks of gestation. The distinction between RPL and general infertility is important: RPL patients can typically conceive — the challenge is sustaining the pregnancy long enough for it to reach viability. Most losses in RPL occur during the first trimester (before 12 weeks), often before couples fully process what is happening.

In clinical practice across Guwahati's fertility landscape, RPL is sometimes under-investigated because patients are told after a first or even second loss to 'try again naturally.' While expectant management has a role, current ESHRE and FOGSI guidelines recommend beginning a structured diagnostic evaluation after two consecutive losses — or even after one loss in women over 35 or those with additional risk factors.

HomeIVF follows evidence-based FOGSI-aligned protocols, meaning Guwahati patients are not asked to wait through unnecessary losses before receiving a proper evaluation. Understanding that RPL is a medical condition — not a personal failure — is the first and most critical step in the journey toward a healthy pregnancy.

RPL is rarely caused by a single factor, and identifying the underlying cause requires a systematic, multi-disciplinary workup. The most common causes can be grouped into five broad categories.

**Chromosomal and Genetic Factors** account for the largest share of early losses. Sporadic chromosomal abnormalities in the embryo — particularly aneuploidies like trisomies — increase with maternal age. In couples where both partners carry balanced translocations or other structural chromosomal rearrangements, the risk of passing on an unbalanced karyotype to the embryo is significantly elevated.

**Uterine Anatomical Abnormalities** such as a septate uterus, submucosal fibroids, intrauterine adhesions (Asherman's syndrome), or a unicornuate uterus physically disrupt implantation or fetal development. These structural issues are among the most actionable causes — many are surgically correctable.

**Hormonal and Endocrine Disorders** including poorly controlled hypothyroidism, elevated prolactin, polycystic ovary syndrome (PCOS), and uncontrolled diabetes are particularly prevalent among women in Guwahati given the high regional burden of thyroid disorders in Northeast India.

**Thrombophilia and Immunological Factors** such as antiphospholipid antibody syndrome (APS) cause abnormal clotting that disrupts placental blood flow — a treatable condition with low-dose aspirin and heparin therapy.

**Unexplained RPL** remains a diagnosis in approximately 40–50% of cases even after full workup. Emerging research points to subclinical uterine natural killer cell abnormalities, sperm DNA fragmentation, and microbiome factors as contributing elements currently being integrated into advanced RPL protocols.

Unlike many fertility conditions, RPL announces itself through a painful and recognisable pattern rather than silent biological changes. The primary presentation is repeated pregnancy loss — but there are often accompanying signals that should prompt earlier investigation.

Vaginal bleeding in early pregnancy is the most common presenting symptom of an impending loss, though not all early bleeding results in miscarriage. Cramping with or without passage of tissue, a sudden disappearance of pregnancy symptoms (nausea, breast tenderness), or an ultrasound showing a fetal heartbeat that subsequently ceases are all patterns that RPL patients in Guwahati often describe experiencing multiple times before they are referred for specialist evaluation.

It is also worth noting what RPL does not always look like. Some losses occur as 'missed miscarriages' — the embryo stops developing but the body does not expel it spontaneously, and the loss is only detected on routine ultrasound. Women in areas like Beltola or Zoo Road who rely on general physicians for pregnancy monitoring may not be receiving the early first-trimester ultrasound surveillance that can catch these situations sooner.

Any woman in Guwahati who has experienced two or more pregnancy losses — regardless of gestational age at the time of loss — should seek a dedicated RPL evaluation rather than waiting for another cycle.

The decision to seek specialist input is often delayed by a combination of hope, social pressure, and a genuine lack of awareness about what structured RPL care looks like. Couples in Guwahati — including those commuting from Dispur or residing in newer residential corridors near Six Mile — frequently report waiting 2–3 years and experiencing 3–4 losses before accessing a formal RPL workup.

FOGSI and the HomeIVF Medical Board recommend consulting a reproductive specialist after: two or more consecutive pregnancy losses at any gestational age; one pregnancy loss accompanied by difficulty conceiving for over 12 months; one pregnancy loss in a woman aged 35 or above; or any loss associated with structural abnormalities detected on ultrasound.

Early consultation does not mean aggressive intervention — it means getting answers. For many couples, understanding the cause (even if it is unexplained RPL) significantly reduces anxiety and allows a medically supervised plan to be put in place before the next attempt. HomeIVF's teleconsultation model means that Guwahati patients can access a senior reproductive specialist from their home in Beltola or Dispur within 24–48 hours of requesting an appointment, without the logistical burden of travelling to a distant fertility clinic.

A comprehensive RPL workup typically unfolds in three parallel streams: genetic testing of the couple and sometimes of pregnancy tissue from a previous loss; uterine evaluation; and systemic medical screening.

**Genetic and Chromosomal Testing** includes peripheral blood karyotyping of both partners to detect balanced translocations or inversions. If products of conception (POC) were preserved from a previous loss, chromosomal microarray or karyotyping of the POC provides the most direct evidence of whether that specific loss was chromosomally abnormal.

**Uterine Assessment** is performed using saline infusion sonography (SIS), hysteroscopy, or 3D transvaginal ultrasound. These modalities can clearly identify a uterine septum, fibroids, polyps, or intrauterine adhesions. For women in Guwahati accessing HomeIVF services, partner diagnostic labs near Zoo Road and across the city are empanelled for these investigations, and results are reviewed centrally by the HomeIVF Medical Board.

**Hormonal and Immunological Panels** cover TSH, free T4, prolactin, fasting insulin, HbA1c, antiphospholipid antibodies (aCL IgG/IgM and anti-beta2 glycoprotein), lupus anticoagulant, and a complete thrombophilia screen. Sperm DNA fragmentation testing is now also recommended for male partners in RPL couples, given emerging evidence of paternal contribution to early loss.

The entire panel can typically be completed within 3–4 weeks, after which the HomeIVF Medical Board reviews findings and prepares a personalised treatment roadmap.

Treatment for RPL is always cause-directed — there is no single universal protocol. However, the range of interventions available through HomeIVF covers the full spectrum of clinically validated RPL management strategies.

**Surgical Correction** of uterine anomalies — such as hysteroscopic septum resection or polyp removal — is coordinated through HomeIVF's partner hospital network in Guwahati. Patients from areas like Beltola who require hysteroscopic procedures are referred to empanelled facilities, with pre- and post-operative monitoring managed via HomeIVF's digital platform.

**Medical Management** of hormonal causes involves thyroid optimisation (TSH targets < 2.5 mIU/L in pregnancy), bromocriptine or cabergoline for hyperprolactinaemia, metformin for insulin-resistant PCOS, and low-dose aspirin plus low-molecular-weight heparin (LMWH) for antiphospholipid antibody syndrome.

**Preimplantation Genetic Testing for Aneuploidies (PGT-A)** combined with IVF is the most powerful tool for couples where embryo chromosomal abnormality is the suspected or confirmed cause of losses. By testing embryos before transfer and selecting only euploid (chromosomally normal) embryos, PGT-A dramatically reduces the risk of chromosomal miscarriage. HomeIVF coordinates IVF with PGT-A for eligible Guwahati couples through its partner labs, with IVF packages starting from ₹1.5 lakh depending on protocol and clinic.

**Progesterone Support** in the luteal phase and early pregnancy — typically via vaginal micronised progesterone — is routinely prescribed for unexplained RPL and shows meaningful benefit in reducing further losses according to the PROMISE and PRISM trials.

One of the most underappreciated stressors in RPL management is the anxiety of the next pregnancy attempt — particularly for couples who have experienced multiple losses and are hyperaware of every symptom. Traditional clinic-based models require women to make frequent in-person visits for blood tests, ultrasounds, and medication adjustments during a time when they may be emotionally fragile and logistically stretched.

HomeIVF's home-monitoring model is specifically designed to address this. Trained phlebotomists visit patients at their homes across Guwahati — including in residential areas like Dispur and Six Mile — for serial beta-hCG and progesterone monitoring in early pregnancy. Results are uploaded to the HomeIVF platform and reviewed by the HomeIVF Medical Board, with medication adjustments or escalation decisions communicated within hours rather than requiring a clinic appointment.

This model offers three tangible benefits for RPL patients: reduced exposure to the anxiety-provoking clinical environment; elimination of travel-related stress during sensitive early pregnancy weeks; and a continuous digital health record that ensures every data point — from initial workup through to delivery — is accessible to the supervising specialist team. For patients in Guwahati who are managing jobs, families, and the emotional weight of RPL simultaneously, this continuity of care at home is not a luxury — it is a clinical necessity.

Despite being Assam's largest city and a regional medical hub, Guwahati presents real structural barriers for couples managing RPL. Specialist reproductive medicine units are concentrated in a small number of private hospitals, creating long wait times. Many couples from areas beyond Zoo Road or Dispur find themselves either under-served by general gynaecologists who lack the bandwidth for detailed RPL workups, or over-reliant on referrals to Kolkata or Bangalore that are financially and logistically prohibitive.

Social and cultural barriers compound the problem. In many communities across Assam, repeated pregnancy loss is still attributed to spiritual causes or personal stress rather than recognised as a treatable medical condition. Women may face pressure to conceive quickly after a loss without adequate recovery time or investigation — a pattern that perpetuates both physical and psychological harm.

HomeIVF addresses these barriers through a combination of technology, accessibility, and education. Its AI-driven platform allows initial symptom assessment and triage in Assamese-friendly digital formats. Senior specialist consultations are available via teleconsultation within 48 hours. Diagnostic coordination across Guwahati's empanelled labs — including facilities accessible from Beltola and Six Mile — ensures that the full RPL panel can be completed locally without a single out-of-state trip. And the HomeIVF Medical Board's structured protocols ensure that every patient, regardless of where they live in Guwahati, receives the same evidence-based standard of RPL care.